Skip to main content
Top
Published in: Current Hypertension Reports 11/2015

01-11-2015 | Preeclampsia (V Garovic, Section Editor)

Preeclampsia: Syndrome or Disease?

Authors: Leslie Myatt, James M. Roberts

Published in: Current Hypertension Reports | Issue 11/2015

Login to get access

Abstract

The focus on disease mechanisms underlying the hypertension and proteinuria defining preeclampsia has increased knowledge of the pathophysiology yet we lack both therapy and predictors. We propose this is in part due to the fact that diagnostic findings identify a “preeclampsia syndrome” but do not necessarily indicate the most important pathophysiology nor if organs are involved as cause or consequence. The increased risk for later life cardiovascular disease in women who develop preeclampsia suggests the stress test of pregnancy exposes pre-existing subclinical vascular disease. The dogma that inadequate trophoblast invasion and ischemia/reperfusion injury to the placenta is “the” cause of preeclampsia is more relevant to early onset preeclampsia (<34 weeks). There is much less evidence for defective placentation in late onset preeclampsia where maternal constitutive factors or susceptibility to vascular damage is more relevant. The contribution of differing disease phenotypes to the syndrome may explain the inability of biomarker studies to identify all preeclampsia. Identification of phenotypes will require large amounts of prospective clinical data and biospecimens, collected in a harmonized manner with analysis in an unbiased discovery approach.
Literature
5.
go back to reference Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;338(11):701–5.PubMedCrossRef Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;338(11):701–5.PubMedCrossRef
9.
go back to reference Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol. 2004;286(4):H1389–93.PubMedCrossRef Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol. 2004;286(4):H1389–93.PubMedCrossRef
10.
go back to reference Collen AC, Hellgren M, Gustafsson H, Johansson MC, Manhem K. Cardiovascular and metabolic characteristics 40 years after hypertensive pregnancies: a long-term follow-up study of mothers. J Hypertens. 2013;31(4):758–65.PubMedCrossRef Collen AC, Hellgren M, Gustafsson H, Johansson MC, Manhem K. Cardiovascular and metabolic characteristics 40 years after hypertensive pregnancies: a long-term follow-up study of mothers. J Hypertens. 2013;31(4):758–65.PubMedCrossRef
12.
go back to reference Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension. 2011;58(4):709–15.PubMedCrossRef Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension. 2011;58(4):709–15.PubMedCrossRef
13.
go back to reference Pouta A, Hartikainen A-L, Sovio U, Gissler M, Laitinen J, McCarthy MI, et al. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension. 2004;43(4):825–31.PubMedCrossRef Pouta A, Hartikainen A-L, Sovio U, Gissler M, Laitinen J, McCarthy MI, et al. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension. 2004;43(4):825–31.PubMedCrossRef
14.
go back to reference Wolf M, Hubel CA, Lam C, Sampson M, Ecker JL, Ness RB, et al. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab. 2004;89(12):6239–43.PubMedCrossRef Wolf M, Hubel CA, Lam C, Sampson M, Ecker JL, Ness RB, et al. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab. 2004;89(12):6239–43.PubMedCrossRef
15.
go back to reference Catov JM, Parks WT, Roberts JM. Early pregnancy lipid and inflammatory markers in women with preterm premature rupture of membranes (PPROM) and preterm labor (PTL). Reprod Sci. 2010;17(3):389. Catov JM, Parks WT, Roberts JM. Early pregnancy lipid and inflammatory markers in women with preterm premature rupture of membranes (PPROM) and preterm labor (PTL). Reprod Sci. 2010;17(3):389.
16.
go back to reference Catov JM, Wu CS, Olsen J, Sutton-Tyrrell K, Li J, Nohr EA. Early or recurrent preterm birth and maternal cardiovascular disease risk. Ann Epidemiol. 2010;20(8):604–9.PubMedCentralPubMedCrossRef Catov JM, Wu CS, Olsen J, Sutton-Tyrrell K, Li J, Nohr EA. Early or recurrent preterm birth and maternal cardiovascular disease risk. Ann Epidemiol. 2010;20(8):604–9.PubMedCentralPubMedCrossRef
17.
go back to reference Germain AM, Romanik MC, Guerra I, Solari S, Reyes MS, Johnson RJ, et al. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?[see comment]. Hypertension. 2007;49(1):90–5.PubMedCrossRef Germain AM, Romanik MC, Guerra I, Solari S, Reyes MS, Johnson RJ, et al. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?[see comment]. Hypertension. 2007;49(1):90–5.PubMedCrossRef
19.
go back to reference Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of pre-eclampsia. J Pathol. 1970;101(4):Pvi.PubMed Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of pre-eclampsia. J Pathol. 1970;101(4):Pvi.PubMed
22.
go back to reference Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–83.PubMedCrossRef Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350(7):672–83.PubMedCrossRef
24.
go back to reference Chappell LC, Seed PT, Kelly FJ, Briley A, Hunt BJ, Charnock-Jones DS, et al. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. Am J Obstet Gynecol. 2002;187(3):777–84.PubMedCrossRef Chappell LC, Seed PT, Kelly FJ, Briley A, Hunt BJ, Charnock-Jones DS, et al. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. Am J Obstet Gynecol. 2002;187(3):777–84.PubMedCrossRef
26.•
go back to reference Kenny LC, Black MA, Poston L, Taylor R, Myers JE, Baker PN, et al. Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the screening for pregnancy endpoints (SCOPE) international cohort study. Hypertension. 2014;64(3):644–52. doi:10.1161/HYPERTENSIONAHA.114.03578. The largest prospective study to date fails to reveal a panel of biomarkers and clinical factors that has clinical utility in prediction of preeclampsia.PubMedCrossRef Kenny LC, Black MA, Poston L, Taylor R, Myers JE, Baker PN, et al. Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the screening for pregnancy endpoints (SCOPE) international cohort study. Hypertension. 2014;64(3):644–52. doi:10.​1161/​HYPERTENSIONAHA.​114.​03578. The largest prospective study to date fails to reveal a panel of biomarkers and clinical factors that has clinical utility in prediction of preeclampsia.PubMedCrossRef
28.
go back to reference Myatt L. Network. ftNM. Do women at high risk develop preeclampsia earlier in gestation than those at low risk? Am J Obstet Gynecol. 2001;184(Suppl):S81. Myatt L. Network. ftNM. Do women at high risk develop preeclampsia earlier in gestation than those at low risk? Am J Obstet Gynecol. 2001;184(Suppl):S81.
29.
go back to reference Myatt L. Network. ftNM. Differences in the time of diagnosis of mild vs severe preeclampsia between low and high risk patient groups. Hypertens Pregnancy. 2002;21 Suppl 1:63. Myatt L. Network. ftNM. Differences in the time of diagnosis of mild vs severe preeclampsia between low and high risk patient groups. Hypertens Pregnancy. 2002;21 Suppl 1:63.
31.
32.
go back to reference Tranquilli AL, Brown MA, Zeeman GG, Dekker G, Sibai BM. The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Pregnancy Hypertens. 2013;3(1):44–7. doi:10.1016/j.preghy.2012.11.001.PubMed Tranquilli AL, Brown MA, Zeeman GG, Dekker G, Sibai BM. The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Pregnancy Hypertens. 2013;3(1):44–7. doi:10.​1016/​j.​preghy.​2012.​11.​001.PubMed
33.
go back to reference Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br Med J. 2001;323(7323):1213–7.CrossRef Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br Med J. 2001;323(7323):1213–7.CrossRef
34.
go back to reference Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death prospective evidence from the child health and development studies cohort. Hypertension. 2010;56(1):166–U264.PubMedCentralPubMedCrossRef Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death prospective evidence from the child health and development studies cohort. Hypertension. 2010;56(1):166–U264.PubMedCentralPubMedCrossRef
36.
39.
41.
go back to reference Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161(5):1200–4.PubMedCrossRef Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989;161(5):1200–4.PubMedCrossRef
42.
go back to reference Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–58.PubMedCentralPubMedCrossRef Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–58.PubMedCentralPubMedCrossRef
43.
go back to reference Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: the “chicken-and-egg” question. Endocrinology. 2004;145(11):4835–7.PubMedCrossRef Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: the “chicken-and-egg” question. Endocrinology. 2004;145(11):4835–7.PubMedCrossRef
44.•
go back to reference Powers RW, Roberts JM, Plymire DA, Pucci D, Datwyler SA, Laird DM, et al. Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia? Hypertension. 2012;60(1):239–46. doi:10.1161/HYPERTENSIONAHA.112.191213. This paper shows that low PlGF is not common to all pregnancies with preeclampsia and reveals different phenotypes based on PLGF levels.PubMedCentralPubMedCrossRef Powers RW, Roberts JM, Plymire DA, Pucci D, Datwyler SA, Laird DM, et al. Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia? Hypertension. 2012;60(1):239–46. doi:10.​1161/​HYPERTENSIONAHA.​112.​191213. This paper shows that low PlGF is not common to all pregnancies with preeclampsia and reveals different phenotypes based on PLGF levels.PubMedCentralPubMedCrossRef
45.
go back to reference Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW, et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond). 2007;112(1):51–7. doi:10.1042/CS20060161.CrossRef Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW, et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond). 2007;112(1):51–7. doi:10.​1042/​CS20060161.CrossRef
46.
47.
go back to reference Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180(2 Pt 1):499–506.PubMedCrossRef Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180(2 Pt 1):499–506.PubMedCrossRef
48.
go back to reference Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab. 2003;88(6):2393–8.PubMedCrossRef Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab. 2003;88(6):2393–8.PubMedCrossRef
50.
go back to reference Leijnse J, de Heus R, Peeters L, Oudijk M, Franx A, Eijkelkamp N. Poor placental vascularization at 12 weeks of pregnancy is associated with a specific cluster of serum proteins. Reprod Sci. 2015;22(S1):69A. Leijnse J, de Heus R, Peeters L, Oudijk M, Franx A, Eijkelkamp N. Poor placental vascularization at 12 weeks of pregnancy is associated with a specific cluster of serum proteins. Reprod Sci. 2015;22(S1):69A.
52.
go back to reference Laivuori H, Lahermo P, Ollikainen V, Widen E, Haiva-Mallinen L, Sundstrom H, et al. Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Genet. 2003;72(1):168–77.PubMedCentralPubMedCrossRef Laivuori H, Lahermo P, Ollikainen V, Widen E, Haiva-Mallinen L, Sundstrom H, et al. Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Genet. 2003;72(1):168–77.PubMedCentralPubMedCrossRef
56.
go back to reference Winn VD, Gormley M, Paquet AC, Kjaer-Sorensen K, Kramer A, Rumer KK, et al. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology. 2009;150(1):452–62. doi:10.1210/en.2008-0990.PubMedCentralPubMedCrossRef Winn VD, Gormley M, Paquet AC, Kjaer-Sorensen K, Kramer A, Rumer KK, et al. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology. 2009;150(1):452–62. doi:10.​1210/​en.​2008-0990.PubMedCentralPubMedCrossRef
57.
go back to reference Yong HE, Melton PE, Johnson MP, Freed KA, Kalionis B, Murthi P, et al. [81-OR]: genome-wide transcriptome directed pathway analysis of maternal preeclampsia susceptibility genes. Hypertens Pregnancy. 2015;5(1):43–4. doi:10.1016/j.preghy.2014.10.085. Yong HE, Melton PE, Johnson MP, Freed KA, Kalionis B, Murthi P, et al. [81-OR]: genome-wide transcriptome directed pathway analysis of maternal preeclampsia susceptibility genes. Hypertens Pregnancy. 2015;5(1):43–4. doi:10.​1016/​j.​preghy.​2014.​10.​085.
58.•
go back to reference Leavey K, Bainbridge SA, Cox BJ. Large scale aggregate microarray analysis reveals three distinct molecular subclasses of human preeclampsia. PLoS One. ;10(2):e0116508. doi:10.1371/journal.pone.0116508. An analysis of 7 placental microarray datasets revealed 3 distinct phenotypes of preeclampsia defined by differences in placental gene expression. Leavey K, Bainbridge SA, Cox BJ. Large scale aggregate microarray analysis reveals three distinct molecular subclasses of human preeclampsia. PLoS One. ;10(2):e0116508. doi:10.​1371/​journal.​pone.​0116508. An analysis of 7 placental microarray datasets revealed 3 distinct phenotypes of preeclampsia defined by differences in placental gene expression.
Metadata
Title
Preeclampsia: Syndrome or Disease?
Authors
Leslie Myatt
James M. Roberts
Publication date
01-11-2015
Publisher
Springer US
Published in
Current Hypertension Reports / Issue 11/2015
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-015-0595-4

Other articles of this Issue 11/2015

Current Hypertension Reports 11/2015 Go to the issue

Pathogenesis of Hypertension (W Elliott, Section Editor)

Clinical Significance of Endothelial Dysfunction in Essential Hypertension

Prevention of Hypertension: Public Health Challenges (P Muntner, Section Editor)

The Utility of Ambulatory Blood Pressure Monitoring for Diagnosing White Coat Hypertension in Older Adults

Prevention of Hypertension: Public Health Challenges (P Muntner, Section Editor)

Mechanisms Influencing Circadian Blood Pressure Patterns Among Individuals with HIV